BLRX
BioLineRX
BLRX
BLRX
26 hedge funds and large institutions have $1.99M invested in BioLineRX in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
61% less capital invested
Capital invested by funds: $5.09M → $1.99M (-$3.1M)
Holders
26
Holding in Top 10
–
Calls
$37K
Puts
$29K
Top Buyers
| 1 | +$96K | |
| 2 | +$90.9K | |
| 3 | +$19.4K | |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$6.8K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.54K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$270K | |
| 3 | -$90.6K | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$69K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$60.4K |